Non-interventional Study to Assess the Number of People With Untreated/Unknown HBV + HDV and HCV in South-East Austria

Recruiting now

Conditions studied: HBV, HCV, HDV, Coinfection, Hepatitis B Coinfection, Hepatitis B

In brief

The HEAL-S study is a non-interventional study with retrospective data analysis. It consists of two parts. First a retrospective analysis based on nucleic acid testing (NAT) results will be performed. Two cohorts (HCV) and (HBV) will be established. Patients falling into one (or both) of the two cohorts will be invited to a prospective linkage-to-care study. In this part, patients are invited to the clinic, where the possibility of hepatitis treatment will be discussed.

Key facts

Study ID

NCT06834178

Run by

Vanessa Stadlbauer-Koellner, MD

People needed

100

Starts

2025-05-01

Expected to finish

2026-10-01

Last updated by the study team

2026-06-18

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• The target population for the HCV cohort consists of individuals with detectable plasma HCV RNA at the latest observation.
• The target population for the HBV cohort consists of individuals with detectable plasma HBV RNA at any time and no recorded HDV testing or a positive HDV serology.

You may not qualify if…

• No valid SVRN (german: Sozialversicherungsnummer, english: Social insurance number)
• No contact details available
• Documented Sustained Virological Response (HCV cohort)
• Documented assessment of HDV status (HBV cohort)

Where it is running

• Department of Internal Medicine, Division of Gastroenterology and Hepatology — Graz, Styra, Austria (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.